Literature DB >> 1094841

Depression, Delusions, and Drug Response.

A H Glassman, S J Kantor, M Shostak.   

Abstract

Depressed patients with delusions were found to be markedly unresponsive to tricyclic drug therapy during an ongoing study of depressed patients. After four weeks of administration of imipramine hydrochloride, only 3 of 13 delusional depressed patients had responded to the drug, but 14 of 21 nondelusional depressed patients had responded. The authors conclude on the basis of these data and those of other researchers that delusional depressed patients should not be treated with tricyclic antidepressants and that current research with depressed patients should be reevaluated in the light of this finding.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1094841     DOI: 10.1176/ajp.132.7.716

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  8 in total

Review 1.  Psychotic major depression: a benefit-risk assessment of treatment options.

Authors:  Audrey R Tyrka; Lawrence H Price; Marcelo F Mello; Andrea F Mello; Linda L Carpenter
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 2.  Plasma level monitoring of tricyclic antidepressant therapy.

Authors:  L F Gram
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

3.  Imipramine: clinical effects and pharmacokinetic variability.

Authors:  N Reisby; L F Gram; P Bech; A Nagy; G O Petersen; J Ortmann; I Ibsen; S J Dencker; O Jacobsen; O Krautwald; I Sondergaard; J Christiansen
Journal:  Psychopharmacology (Berl)       Date:  1977-11-15       Impact factor: 4.530

Review 4.  Measurement of serum drug levels in the assessment of antidepressants.

Authors:  S A Montgomery
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

Review 5.  Subtypes of depression--diagnosis and medical management.

Authors:  R J Bielski; R O Friedel
Journal:  West J Med       Date:  1977-05

6.  Prolactin stimulating effects of amoxapine and loxapine in psychiatric patients.

Authors:  A G Robertson; R Berry; H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.

Authors:  H H Berendsen; C L Broekkamp
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 8.  Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities.

Authors:  Renana Eitan; Bernard Lerer
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.